SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

07 Nov 2023 Evaluate
The topline stands at Rs. 986.39 millions for the September 2023 quarter. The mentioned figure indicates a rise of about 83.95% as against Rs. 536.23 millions during the year-ago period.A big decline of -40.39% was reported for the quarter ended September 2023 to Rs. 106.63  millions from Rs. 178.87 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 144.91 millions from 206.43 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 986.39 536.23 83.95 1644.99 1248.03 31.81 2730.95 2045.20 33.53
Other Income 57.89 147.38 -60.72 72.71 149.11 -51.24 160.86 80.27 100.40
PBIDT 144.91 206.43 -29.80 167.93 272.99 -38.48 439.99 234.40 87.71
Interest 7.45 6.13 21.53 16.97 11.08 53.16 26.72 29.53 -9.52
PBDT 137.46 200.30 -31.37 150.96 261.91 -42.36 413.27 204.87 101.72
Depreciation 11.63 11.23 3.56 22.87 22.04 3.77 44.12 43.23 2.06
PBT 125.83 189.07 -33.45 128.09 239.87 -46.60 369.15 161.64 128.38
TAX 19.20 10.20 88.24 19.92 22.96 -13.24 56.63 44.20 28.12
Deferred Tax -0.08 -1.74 -95.40 -0.63 -2.76 -77.17 -2.09 6.73 -131.05
PAT 106.63 178.87 -40.39 108.17 216.91 -50.13 312.52 117.44 166.11
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.12 482.12 0.00
PBIDTM(%) 14.69 38.50 -61.84 10.21 21.87 -53.33 16.11 11.46 40.57

Kopran Share Price

159.60 4.70 (3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×